Alta Partners Management VIII, LLC
Insider CIK 1399894 · AGTC 10% owner · LIFE 10% owner · STRO 10% owner · TRVN 10% owner · ESPR 10% owner · IMDZ 10% owner · ZSPH 10% owner · ALLK 10% owner · NEOT 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ALLK Allakos Inc. | J Other | 2023-08-16 | 2023-08-18 | 1,463,378 | — | $0 | 1,463,378 | SEC↗ |
| ALLK Allakos Inc. | J Other | 2023-08-16 | 2023-08-18 | 1,463,378 | — | $0 | 0 | SEC↗ |
| ALLK Allakos Inc. | J Other | 2023-08-16 | 2023-08-18 | 6,448,053 | — | $0 | 0 | SEC↗ |
| ALLK Allakos Inc. | J Other | 2021-01-04 | 2021-01-06 | 486,230 | — | $0 | 2,071,147 | SEC↗ |
| ALLK Allakos Inc. | J Other | 2021-01-04 | 2021-01-06 | 102,651 | — | $0 | 102,651 | SEC↗ |
| ALLK Allakos Inc. | J Other | 2021-01-04 | 2021-01-06 | 102,651 | — | $0 | 0 | SEC↗ |
| ALLK Allakos Inc. | J Other | 2021-01-04 | 2021-01-06 | 1,513,770 | — | $0 | 6,448,053 | SEC↗ |
| ALLK Allakos Inc. | J Other | 2021-01-04 | 2021-01-06 | 339,084 | — | $0 | 339,084 | SEC↗ |
| ALLK Allakos Inc. | J Other | 2021-01-04 | 2021-01-06 | 339,084 | — | $0 | 0 | SEC↗ |
| ALLK Allakos Inc. | J Other | 2020-01-22 | 2020-01-24 | 11,538 | — | $0 | 11,538 | SEC↗ |
| ALLK Allakos Inc. | J Other | 2020-01-22 | 2020-01-24 | 11,539 | — | $0 | 11,539 | SEC↗ |
| ALLK Allakos Inc. | J Other | 2020-01-22 | 2020-01-24 | 11,538 | — | $0 | 11,538 | SEC↗ |
| ALLK Allakos Inc. | J Other | 2020-01-22 | 2020-01-24 | 6,837 | — | $0 | 6,837 | SEC↗ |
| ALLK Allakos Inc. | J Other | 2020-01-22 | 2020-01-24 | 34,615 | — | $0 | 0 | SEC↗ |
| ALLK Allakos Inc. | J Other | 2020-01-22 | 2020-01-24 | 34,615 | — | $0 | 34,615 | SEC↗ |
| ALLK Allakos Inc. | J Other | 2020-01-22 | 2020-01-24 | 1,000,000 | — | $0 | 10,519,200 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-01 | 12,387,324 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-01 | 9,449,318 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-01 | 18,698,578 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-01 | 10,201,769 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-01 | 458,331 | — | $0 | 1,047,992 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-01 | 589,661 | — | $0 | 589,661 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-01 | 382,698 | — | $0 | 1,430,690 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-01 | 514,211 | — | $0 | 1,944,901 | SEC↗ |
| ALLK Allakos Inc. | C Conversion deriv | 2018-07-23 | 2018-07-23 | 1,239,007 | — | $0 | 0 | SEC↗ |
| ALLK Allakos Inc. | C Conversion deriv | 2018-07-23 | 2018-07-23 | 10,030,193 | — | $0 | 0 | SEC↗ |
| ALLK Allakos Inc. | C Conversion | 2018-07-23 | 2018-07-23 | 11,269,200 | — | $0 | 11,269,200 | SEC↗ |
| ALLK Allakos Inc. | P Buy | 2018-07-23 | 2018-07-23 | 250,000 | $18.00 | $4.50M | 11,519,200 | SEC↗ |
| NEOT Neothetics, Inc. | S Sale | 2015-12-30 | 2015-12-30 | 250,000 | $1.44 | $360.0K | 1,339,776 | SEC↗ |
| NEOT Neothetics, Inc. | S Sale | 2015-12-29 | 2015-12-30 | 493,654 | $1.53 | $755.3K | 1,589,776 | SEC↗ |
| NEOT Neothetics, Inc. | S Sale | 2015-12-28 | 2015-12-30 | 54,333 | $1.59 | $86.4K | 2,083,430 | SEC↗ |
| NEOT Neothetics, Inc. | S Sale | 2015-12-15 | 2015-12-17 | 529,261 | $1.44 | $762.1K | 2,137,763 | SEC↗ |
| ZSPH ZS Pharma, Inc. | S Sale | 2015-06-08 | 2015-06-09 | 11,200 | $57.53 | $644.3K | 2,646,643 | SEC↗ |
| ZSPH ZS Pharma, Inc. | S Sale | 2015-06-05 | 2015-06-09 | 164,227 | $57.88 | $9.51M | 2,657,843 | SEC↗ |
| ZSPH ZS Pharma, Inc. | S Sale | 2015-06-04 | 2015-06-05 | 48,913 | $57.71 | $2.82M | 2,822,070 | SEC↗ |
| ZSPH ZS Pharma, Inc. | S Sale | 2015-06-04 | 2015-06-05 | 39,495 | $57.21 | $2.26M | 2,870,983 | SEC↗ |
| ZSPH ZS Pharma, Inc. | S Sale | 2015-06-03 | 2015-06-05 | 23,189 | $56.60 | $1.31M | 2,910,478 | SEC↗ |
| ZSPH ZS Pharma, Inc. | S Sale | 2015-06-02 | 2015-06-02 | 84,342 | $56.77 | $4.79M | 2,933,667 | SEC↗ |
| ZSPH ZS Pharma, Inc. | S Sale | 2015-06-01 | 2015-06-02 | 72,520 | $58.00 | $4.21M | 3,018,009 | SEC↗ |
| ZSPH ZS Pharma, Inc. | S Sale | 2015-05-29 | 2015-06-02 | 124,865 | $58.63 | $7.32M | 3,105,225 | SEC↗ |
| ZSPH ZS Pharma, Inc. | S Sale | 2015-05-29 | 2015-06-02 | 14,696 | $59.69 | $877.2K | 3,090,529 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion deriv | 2015-05-12 | 2015-05-14 | 893,655 | — | $0 | 0 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion deriv | 2015-05-12 | 2015-05-14 | 4,361,703 | — | $0 | 0 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion deriv | 2015-05-12 | 2015-05-14 | 4,320,173 | — | $0 | 0 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion deriv | 2015-05-12 | 2015-05-14 | 3,600,000 | — | $0 | 0 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion deriv | 2015-05-12 | 2015-05-14 | 1,126,866 | — | $0 | 0 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion | 2015-05-12 | 2015-05-14 | 1,685,758 | — | $0 | 1,685,758 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion | 2015-05-12 | 2015-05-14 | 92,306 | — | $0 | 1,778,064 | SEC↗ |
| TRVN TREVENA INC | P Buy | 2014-12-10 | 2014-12-10 | 500,000 | $4.00 | $2.00M | 4,390,262 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-11-25 | 750,000 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-11-25 | 6,216,215 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-11-25 | 2,201,220 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion deriv | 2014-11-25 | 2014-11-25 | 4,489,065 | — | $0 | 0 | SEC↗ |
| NEOT Neothetics, Inc. | X Exercise deriv | 2014-11-25 | 2014-11-25 | 707,142 | $1.40 | $990.0K | 0 | SEC↗ |
| NEOT Neothetics, Inc. | X Exercise deriv | 2014-11-25 | 2014-11-25 | 432,432 | $1.85 | $800.0K | 0 | SEC↗ |
| NEOT Neothetics, Inc. | X Exercise deriv | 2014-11-25 | 2014-11-25 | 214,285 | $1.40 | $300.0K | 0 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion | 2014-11-25 | 2014-11-25 | 1,161,939 | — | $0 | 1,288,824 | SEC↗ |
| NEOT Neothetics, Inc. | P Buy | 2014-11-25 | 2014-11-25 | 70,000 | $14.00 | $980.0K | 2,667,024 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion | 2014-11-25 | 2014-11-25 | 476,845 | — | $0 | 1,765,669 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion | 2014-11-25 | 2014-11-25 | 735,912 | — | $0 | 2,501,581 | SEC↗ |
| NEOT Neothetics, Inc. | X Exercise | 2014-11-25 | 2014-11-25 | 93,676 | $11.29 | $1.06M | 2,595,257 | SEC↗ |
| NEOT Neothetics, Inc. | S Sale | 2014-11-25 | 2014-11-25 | 57,143 | $14.00 | $800.0K | 2,538,114 | SEC↗ |
| NEOT Neothetics, Inc. | X Exercise | 2014-11-25 | 2014-11-25 | 115,925 | $8.54 | $990.0K | 2,654,039 | SEC↗ |
| NEOT Neothetics, Inc. | S Sale | 2014-11-25 | 2014-11-25 | 70,714 | $14.00 | $990.0K | 2,583,325 | SEC↗ |
| NEOT Neothetics, Inc. | X Exercise | 2014-11-25 | 2014-11-25 | 35,128 | $8.54 | $300.0K | 2,618,453 | SEC↗ |
| NEOT Neothetics, Inc. | S Sale | 2014-11-25 | 2014-11-25 | 21,429 | $14.00 | $300.0K | 2,597,024 | SEC↗ |
| NEOT Neothetics, Inc. | C Conversion | 2014-11-25 | 2014-11-25 | 122,951 | — | $0 | 126,885 | SEC↗ |
| NEOT Neothetics, Inc. | X Exercise | 2014-11-25 | 2014-12-01 | 93,676 | $8.54 | $800.0K | 2,595,257 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | J Other | 2014-11-17 | 2014-11-19 | 1,492,200 | — | $0 | 1,492,200 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | P Buy | 2014-10-21 | 2014-10-21 | 500,000 | $20.00 | $10.00M | 2,552,189 | SEC↗ |
| IMDZ Immune Design Corp. | C Conversion deriv | 2014-07-29 | 2014-07-31 | 611,620 | — | $0 | 0 | SEC↗ |
| IMDZ Immune Design Corp. | X Exercise deriv | 2014-07-29 | 2014-07-31 | 305,810 | — | $0 | 305,810 | SEC↗ |
| IMDZ Immune Design Corp. | X Exercise deriv | 2014-07-29 | 2014-07-31 | 305,810 | — | $0 | 0 | SEC↗ |
| IMDZ Immune Design Corp. | C Conversion deriv | 2014-07-29 | 2014-07-31 | 305,810 | — | $0 | 0 | SEC↗ |
| IMDZ Immune Design Corp. | C Conversion deriv | 2014-07-29 | 2014-07-31 | 531,843 | — | $0 | 0 | SEC↗ |
| IMDZ Immune Design Corp. | C Conversion deriv | 2014-07-29 | 2014-07-31 | 733,943 | — | $0 | 0 | SEC↗ |
| IMDZ Immune Design Corp. | C Conversion | 2014-07-29 | 2014-07-31 | 611,620 | — | $0 | 1,877,406 | SEC↗ |
| IMDZ Immune Design Corp. | P Buy | 2014-07-29 | 2014-07-31 | 299,559 | $12.00 | $3.59M | 2,482,775 | SEC↗ |
| IMDZ Immune Design Corp. | C Conversion | 2014-07-29 | 2014-07-31 | 733,943 | — | $0 | 733,943 | SEC↗ |
| IMDZ Immune Design Corp. | C Conversion | 2014-07-29 | 2014-07-31 | 305,810 | — | $0 | 2,183,216 | SEC↗ |
| IMDZ Immune Design Corp. | C Conversion | 2014-07-29 | 2014-07-31 | 531,843 | — | $0 | 1,265,786 | SEC↗ |
| ZSPH ZS Pharma, Inc. | C Conversion deriv | 2014-06-23 | 2014-06-25 | 2,849,703 | — | $0 | 0 | SEC↗ |
| ZSPH ZS Pharma, Inc. | C Conversion deriv | 2014-06-23 | 2014-06-25 | 180,387 | — | $0 | 0 | SEC↗ |
| ZSPH ZS Pharma, Inc. | C Conversion | 2014-06-23 | 2014-06-25 | 3,030,090 | — | $0 | 3,030,090 | SEC↗ |
| ZSPH ZS Pharma, Inc. | P Buy | 2014-06-23 | 2014-06-25 | 200,000 | $18.00 | $3.60M | 3,230,090 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | C Conversion deriv | 2014-04-01 | 2014-04-01 | 23,507,953 | — | $0 | 0 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | C Conversion deriv | 2014-04-01 | 2014-04-01 | 49,060,606 | — | $0 | 0 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | C Conversion deriv | 2014-04-01 | 2014-04-01 | 26,437,934 | — | $0 | 0 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | P Buy | 2014-04-01 | 2014-04-01 | 155,645 | $12.00 | $1.87M | 2,984,400 | SEC↗ |
| AGTC APPLIED GENETIC TECHNOLOGI | C Conversion | 2014-04-01 | 2014-04-01 | 2,828,755 | — | $0 | 2,828,755 | SEC↗ |
| TRVN TREVENA INC | C Conversion deriv | 2014-02-05 | 2014-02-07 | 4,840,686 | — | $0 | 0 | SEC↗ |
| TRVN TREVENA INC | C Conversion deriv | 2014-02-05 | 2014-02-07 | 1,950,000 | — | $0 | 0 | SEC↗ |
| TRVN TREVENA INC | C Conversion deriv | 2014-02-05 | 2014-02-07 | 8,400,000 | — | $0 | 0 | SEC↗ |
| TRVN TREVENA INC | C Conversion deriv | 2014-02-05 | 2014-02-07 | 6,000,000 | — | $0 | 0 | SEC↗ |
| TRVN TREVENA INC | P Buy | 2014-02-05 | 2014-02-07 | 472,410 | $7.00 | $3.31M | 3,890,262 | SEC↗ |
| TRVN TREVENA INC | C Conversion | 2014-02-05 | 2014-02-07 | 1,354,838 | — | $0 | 2,322,579 | SEC↗ |
| TRVN TREVENA INC | C Conversion | 2014-02-05 | 2014-02-07 | 967,741 | — | $0 | 967,741 | SEC↗ |
| TRVN TREVENA INC | C Conversion | 2014-02-05 | 2014-02-07 | 314,516 | — | $0 | 2,637,095 | SEC↗ |
| TRVN TREVENA INC | C Conversion | 2014-02-05 | 2014-02-07 | 780,757 | — | $0 | 3,417,852 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | J Other deriv | 2013-07-01 | 2013-07-01 | 71,237 | — | $0 | 71,237 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | J Other deriv | 2013-07-01 | 2013-07-01 | 497,666 | — | $0 | 0 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | C Conversion deriv | 2013-07-01 | 2013-07-01 | 1,816,475 | — | $0 | 0 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | P Buy | 2013-07-01 | 2013-07-01 | 235,714 | $14.00 | $3.30M | 2,052,189 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | C Conversion | 2013-07-01 | 2013-07-01 | 1,816,475 | — | $0 | 1,816,475 | SEC↗ |